Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-TNF therapy and semen quality in male patients with inflammatory bowel disease
NL-OMON33788Recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2009
- Countries
- 1
01
Overview
Open-label, single-arm trial in inflammatory bowel disease (IBD), sponsored by Erasmus MC. Primary endpoints: Change in semen quality and quantity at month 3 and Change in semen quality and quantity at month 6. Started Dec 2009; status: recruiting.
02
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON33788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33788.